|
Rocephin 1g I.V
Ceftriaxone (as Ceftriaxon sodium) 1g
- Strength / route
- 1g · Injection
- Qty
- 10,500 Vial
- Total
- 1,474,368,000
- Group
- N1
- Manufacturer
- F.Hoffmann-La Roche Ltd. (Switzerland)
- Province / Facility
- Quang Nam · 49004
|
VN-17036-13 |
1g
Injection
|
Vial |
10,500
|
140,416
|
1,474,368,000
|
N1 |
F.Hoffmann-La Roche Ltd.
Switzerland
|
Quang Nam
49004
|
2026-03-23 |
|
Rocephin 1g I.V
Ceftriaxone (as Ceftriaxon sodium) 1g
- Strength / route
- 1g · Injection
- Qty
- 0 Vial
- Total
- 0
- Group
- N1
- Manufacturer
- F.Hoffmann-La Roche Ltd. (Switzerland)
- Province / Facility
- Quang Nam · 49901
|
VN-17036-13 |
1g
Injection
|
Vial |
0
|
140,416
|
0
|
N1 |
F.Hoffmann-La Roche Ltd.
Switzerland
|
Quang Nam
49901
|
2026-03-23 |
|
SMOFlipid 20%
Nhu dich lipid
- Strength / route
- (6g; 6g; 5g; 3g)/100ml · Infusion
- Qty
- 500 Chai
- Total
- 67,500,000
- Group
- N1
- Manufacturer
- Fresenius Kabi Austria GmbH (Austria)
- Province / Facility
- Can Tho · 92003
|
VN-19955-16 |
(6g; 6g; 5g; 3g)/100ml
Infusion
|
Chai |
500
|
135,000
|
67,500,000
|
N1 |
Fresenius Kabi Austria GmbH
Austria
|
Can Tho
92003
|
2026-03-23 |
|
SaViDopril Plus
Perindopril erbumin + Indapamid hemihydrat
- Strength / route
- 4mg + 1,25mg · Oral
- Qty
- 150,000 Tablet
- Total
- 270,000,000
- Group
- N2
- Manufacturer
- SaVi Pharmaceutical JSC (Vietnam)
- Province / Facility
- Ha Tinh · 42009
|
893110072200 |
4mg + 1,25mg
Oral
|
Tablet |
150,000
|
1,800
|
270,000,000
|
N2 |
SaVi Pharmaceutical JSC
Vietnam
|
Ha Tinh
42009
|
2026-03-23 |
|
Sandostatin Lar 20 mg
Octreotid
- Strength / route
- 20mg · Injection
- Qty
- 50 Vial
- Total
- 1,342,655,300
- Group
- N1
- Manufacturer
- Manufacturing site: Novartis Pharmaceutical Manufacturing GmbH; Secondary packaging and batch release site: Abbott Biologicals B.V.; Solvent for injection manufacturing site: Abbott Biologicals B.V. (Austria, Secondary packaging, batch release and solvent manufacturing site: Netherlands)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-20047-16 |
20mg
Injection
|
Vial |
50
|
26,853,106
|
1,342,655,300
|
N1 |
Manufacturing site: Novartis Pharmaceutical Manufacturing GmbH; Secondary packaging and batch release site: Abbott Biologicals B.V.; Solvent for injection manufacturing site: Abbott Biologicals B.V.
Austria, Secondary packaging, batch release and solvent manufacturing site: Netherlands
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Sandostatin Lar 30 mg
Octreotid
- Strength / route
- 30mg · Injection
- Qty
- 100 Vial
- Total
- 3,320,752,500
- Group
- N1
- Manufacturer
- Manufacturing site: Novartis Pharmaceutical Manufacturing GmbH; Secondary packaging and batch release site: Abbott Biologicals B.V.; Solvent for injection manufacturing site: Abbott Biologicals B.V. (Austria, Secondary packaging, batch release and solvent manufacturing site: Netherlands)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-20048-16 |
30mg
Injection
|
Vial |
100
|
33,207,525
|
3,320,752,500
|
N1 |
Manufacturing site: Novartis Pharmaceutical Manufacturing GmbH; Secondary packaging and batch release site: Abbott Biologicals B.V.; Solvent for injection manufacturing site: Abbott Biologicals B.V.
Austria, Secondary packaging, batch release and solvent manufacturing site: Netherlands
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Sanlein 0.3
Natri hyaluronat
- Strength / route
- 15mg/5ml · Ophthalmic
- Qty
- 3,600 Vial
- Total
- 453,600,000
- Group
- N1
- Manufacturer
- Santen Pharmaceutical Co., Ltd.-Noto Plant (Japan)
- Province / Facility
- Thua Thien Hue · 46204
|
VN-19343-15 |
15mg/5ml
Ophthalmic
|
Vial |
3,600
|
126,000
|
453,600,000
|
N1 |
Santen Pharmaceutical Co., Ltd.-Noto Plant
Japan
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Sanlein 0.3
Natri hyaluronat
- Strength / route
- 15mg/5ml · Ophthalmic
- Qty
- 12,000 Vial
- Total
- 1,512,000,000
- Group
- N1
- Manufacturer
- Santen Pharmaceutical Co., Ltd.-Noto Plant (Japan)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-19343-15 |
15mg/5ml
Ophthalmic
|
Vial |
12,000
|
126,000
|
1,512,000,000
|
N1 |
Santen Pharmaceutical Co., Ltd.-Noto Plant
Japan
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Sanlein Mini 0.1
Natri hyaluronat
- Strength / route
- 0,4mg/0,4ml · Ophthalmic
- Qty
- 3,000 Vial
- Total
- 11,655,000
- Group
- N1
- Manufacturer
- Santen Pharmaceutical Co., Ltd. – Noto Plant (Japan)
- Province / Facility
- Thua Thien Hue · 46204
|
499100415323 |
0,4mg/0,4ml
Ophthalmic
|
Vial |
3,000
|
3,885
|
11,655,000
|
N1 |
Santen Pharmaceutical Co., Ltd. – Noto Plant
Japan
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Sanlein Mini 0.1
Natri hyaluronat
- Strength / route
- 0,4mg/0,4ml · Ophthalmic
- Qty
- 6,000 Vial
- Total
- 23,310,000
- Group
- N1
- Manufacturer
- Santen Pharmaceutical Co., Ltd. – Noto Plant (Japan)
- Province / Facility
- Thua Thien Hue · 46001
|
499100415323 |
0,4mg/0,4ml
Ophthalmic
|
Vial |
6,000
|
3,885
|
23,310,000
|
N1 |
Santen Pharmaceutical Co., Ltd. – Noto Plant
Japan
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Seretide Accuhaler 50/250mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg + Fluticason propionat 250mcg · Oral inhalation
- Qty
- 6,000 Canister
- Total
- 1,199,328,000
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (USA)
- Province / Facility
- Quang Nam · 49004
|
001110013824 |
each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg + Fluticason propionat 250mcg
Oral inhalation
|
Canister |
6,000
|
199,888
|
1,199,328,000
|
N1 |
GlaxoSmithKline LLC
USA
|
Quang Nam
49004
|
2026-03-23 |
|
Seretide Accuhaler 50/250mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg + Fluticason propionat 250mcg · Oral inhalation
- Qty
- 0 Canister
- Total
- 0
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (USA)
- Province / Facility
- Quang Nam · 49901
|
001110013824 |
each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg + Fluticason propionat 250mcg
Oral inhalation
|
Canister |
0
|
199,888
|
0
|
N1 |
GlaxoSmithKline LLC
USA
|
Quang Nam
49901
|
2026-03-23 |
|
Seretide Accuhaler 50/500mcg
Salmeterol+ fluticason propionat
- Strength / route
- 50mcg + 500mcg · Inhalation
- Qty
- 3,000 Canister
- Total
- 655,836,000
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (United States)
- Province / Facility
- Thua Thien Hue · 46204
|
VN-20767-17 |
50mcg + 500mcg
Inhalation
|
Canister |
3,000
|
218,612
|
655,836,000
|
N1 |
GlaxoSmithKline LLC
United States
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Seretide Accuhaler 50/500mcg
Salmeterol+ fluticason propionat
- Strength / route
- (50mcg + 500mcg) - 60 dose · Inhalation
- Qty
- 360 Canister
- Total
- 78,700,320
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (United States)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-20767-17 |
(50mcg + 500mcg) - 60 dose
Inhalation
|
Canister |
360
|
218,612
|
78,700,320
|
N1 |
GlaxoSmithKline LLC
United States
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Seretide Evohaler DC 25/125mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose xit contains: Salmeterol (dang Salmeterol xinafoate micronised) 25mcg + Fluticasone propionate (dang micronised) 125mcg · Oral inhalation
- Qty
- 5,000 Spray canister
- Total
- 1,050,880,000
- Group
- N1
- Manufacturer
- Glaxo Wellcome S.A. (Spain)
- Province / Facility
- Quang Nam · 49004
|
840110784024 |
each dose xit contains: Salmeterol (dang Salmeterol xinafoate micronised) 25mcg + Fluticasone propionate (dang micronised) 125mcg
Oral inhalation
|
Spray canister |
5,000
|
210,176
|
1,050,880,000
|
N1 |
Glaxo Wellcome S.A.
Spain
|
Quang Nam
49004
|
2026-03-23 |
|
Seretide Evohaler DC 25/125mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose xit contains: Salmeterol (dang Salmeterol xinafoate micronised) 25mcg + Fluticasone propionate (dang micronised) 125mcg · Oral inhalation
- Qty
- 0 Spray canister
- Total
- 0
- Group
- N1
- Manufacturer
- Glaxo Wellcome S.A. (Spain)
- Province / Facility
- Quang Nam · 49901
|
840110784024 |
each dose xit contains: Salmeterol (dang Salmeterol xinafoate micronised) 25mcg + Fluticasone propionate (dang micronised) 125mcg
Oral inhalation
|
Spray canister |
0
|
210,176
|
0
|
N1 |
Glaxo Wellcome S.A.
Spain
|
Quang Nam
49901
|
2026-03-23 |
|
Seroquel XR
Quetiapin
- Strength / route
- 50mg · Oral
- Qty
- 24,000 Tablet
- Total
- 251,328,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging site: AstraZeneca UK Limited. (United States, Packaging site: United Kingdom)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-22285-19 |
50mg
Oral
|
Tablet |
24,000
|
10,472
|
251,328,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging site: AstraZeneca UK Limited.
United States, Packaging site: United Kingdom
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Sevorane
Sevofluran
- Strength / route
- each chai 250ml contains: Sevofluran 250ml · Inhalation
- Qty
- 180 Chai
- Total
- 644,130,000
- Group
- N1
- Manufacturer
- Abbvie S.r.l (Italy)
- Province / Facility
- Quang Nam · 49004
|
800114034723 |
each chai 250ml contains: Sevofluran 250ml
Inhalation
|
Chai |
180
|
3,578,500
|
644,130,000
|
N1 |
Abbvie S.r.l
Italy
|
Quang Nam
49004
|
2026-03-23 |
|
Sevorane
Sevofluran
- Strength / route
- each chai 250ml contains: Sevofluran 250ml · Inhalation
- Qty
- 0 Chai
- Total
- 0
- Group
- N1
- Manufacturer
- Abbvie S.r.l (Italy)
- Province / Facility
- Quang Nam · 49901
|
800114034723 |
each chai 250ml contains: Sevofluran 250ml
Inhalation
|
Chai |
0
|
3,578,500
|
0
|
N1 |
Abbvie S.r.l
Italy
|
Quang Nam
49901
|
2026-03-23 |
|
Sevorane
Sevofluran
- Strength / route
- 250ml · Inhalation
- Qty
- 900 Chai
- Total
- 3,220,650,000
- Group
- N1
- Manufacturer
- Abbvie S.r.l (Italy)
- Province / Facility
- Thua Thien Hue · 46204
|
800114034723 |
250ml
Inhalation
|
Chai |
900
|
3,578,500
|
3,220,650,000
|
N1 |
Abbvie S.r.l
Italy
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Sevorane
Sevofluran
- Strength / route
- 250ml · Inhalation
- Qty
- 7,200 Chai
- Total
- 25,765,200,000
- Group
- N1
- Manufacturer
- Abbvie S.r.l (Italy)
- Province / Facility
- Thua Thien Hue · 46001
|
800114034723 |
250ml
Inhalation
|
Chai |
7,200
|
3,578,500
|
25,765,200,000
|
N1 |
Abbvie S.r.l
Italy
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Singulair
Natri montelukast
- Strength / route
- 10mg · Oral
- Qty
- 2,400 Tablet
- Total
- 32,404,800
- Group
- N1
- Manufacturer
- Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.) (United Kingdom (Packaging site: Netherlands))
- Province / Facility
- Thua Thien Hue · 46204
|
500110412923 |
10mg
Oral
|
Tablet |
2,400
|
13,502
|
32,404,800
|
N1 |
Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.)
United Kingdom (Packaging site: Netherlands)
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Singulair
Natri montelukast
- Strength / route
- 10mg · Oral
- Qty
- 12,000 Tablet
- Total
- 162,024,000
- Group
- N1
- Manufacturer
- Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.) (United Kingdom, Packaging site: Netherlands)
- Province / Facility
- Thua Thien Hue · 46001
|
500110412923 |
10mg
Oral
|
Tablet |
12,000
|
13,502
|
162,024,000
|
N1 |
Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.)
United Kingdom, Packaging site: Netherlands
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Singulair
Natri montelukast
- Strength / route
- 10mg · Oral
- Qty
- 2,200 Tablet
- Total
- 29,704,400
- Group
- N1
- Manufacturer
- Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.) (United Kingdom (Packaging site: Netherlands))
- Province / Facility
- Hanoi · 01056
|
500110412923 |
10mg
Oral
|
Tablet |
2,200
|
13,502
|
29,704,400
|
N1 |
Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.)
United Kingdom (Packaging site: Netherlands)
|
Hanoi
01056
|
2026-03-23 |
|
Singulair 4mg
Natri montelukast
- Strength / route
- 4mg · Oral
- Qty
- 1,500 Tablet
- Total
- 20,253,000
- Group
- N1
- Manufacturer
- Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.) (United Kingdom (Packaging site: Netherlands))
- Province / Facility
- Thua Thien Hue · 46204
|
VN-20318-17 |
4mg
Oral
|
Tablet |
1,500
|
13,502
|
20,253,000
|
N1 |
Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.)
United Kingdom (Packaging site: Netherlands)
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Singulair 4mg (đóng gói tại Merck Sharp & Dohme B.V. Địa chỉ: Waarderweg 39, 2031 BN Haarlem- Netherlands))
Natri montelukast
- Strength / route
- 4mg · Oral
- Qty
- 4,000 Tablet
- Total
- 54,008,000
- Group
- N1
- Manufacturer
- Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.) (United Kingdom, Packaging site: Netherlands)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-20318-17 |
4mg
Oral
|
Tablet |
4,000
|
13,502
|
54,008,000
|
N1 |
Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.)
United Kingdom, Packaging site: Netherlands
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Singulair 5mg
Natri montelukast
- Strength / route
- 5mg · Oral
- Qty
- 1,700 Tablet
- Total
- 22,953,400
- Group
- N1
- Manufacturer
- Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.) (United Kingdom (Packaging site: Netherlands))
- Province / Facility
- Hanoi · 01056
|
VN-20319-17 |
5mg
Oral
|
Tablet |
1,700
|
13,502
|
22,953,400
|
N1 |
Organon Pharma (UK) Limited (Packaging site: Merck Sharp & Dohme B.V.)
United Kingdom (Packaging site: Netherlands)
|
Hanoi
01056
|
2026-03-23 |
|
Smecta
Diosmectite
- Strength / route
- 3 gam · Oral
- Qty
- 20,000 Sachet
- Total
- 81,640,000
- Group
- N1
- Manufacturer
- Mayoly Industrie (France)
- Province / Facility
- Ha Tinh · 42009
|
VN-19485-15 |
3 gam
Oral
|
Sachet |
20,000
|
4,082
|
81,640,000
|
N1 |
Mayoly Industrie
France
|
Ha Tinh
42009
|
2026-03-23 |
|
Solu - Medrol
Methyl prednisolon
- Strength / route
- 40mg · Injection
- Qty
- 120,000 Vial
- Total
- 5,024,520,000
- Group
- N1
- Manufacturer
- Pfizer Manufacturing Belgium NV (Belgium)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-20330-17 |
40mg
Injection
|
Vial |
120,000
|
41,871
|
5,024,520,000
|
N1 |
Pfizer Manufacturing Belgium NV
Belgium
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Solu - Medrol
Methylprednisolon (as Methylprednisolon sodium succinate) 40 mg
- Strength / route
- 40mg · Intravenous injection/infusion, intramuscular (IV, IM)
- Qty
- 7,000 Vial
- Total
- 293,097,000
- Group
- N1
- Manufacturer
- Pfizer Manufacturing Belgium NV (Belgium)
- Province / Facility
- Nghe An · 40025
|
VN-20330-17 |
40mg
Intravenous injection/infusion, intramuscular (IV, IM)
|
Vial |
7,000
|
41,871
|
293,097,000
|
N1 |
Pfizer Manufacturing Belgium NV
Belgium
|
Nghe An
40025
|
2026-03-23 |
|
Solu-Medrol
Methyl prednisolon
- Strength / route
- 40mg · Injection
- Qty
- 36,000 Vial
- Total
- 1,507,356,000
- Group
- N1
- Manufacturer
- Pfizer Manufacturing Belgium NV (Bỉ)
- Province / Facility
- Thua Thien Hue · 46204
|
VN-20330-17 |
40mg
Injection
|
Vial |
36,000
|
41,871
|
1,507,356,000
|
N1 |
Pfizer Manufacturing Belgium NV
Bỉ
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Sulfadiazin bạc
Sulfadiazin bac
- Strength / route
- 1%, tube 20g · Topical
- Qty
- 0 Tube
- Total
- 0
- Group
- N4
- Manufacturer
- Medipharco Pharmaceutical JSC (Vietnam)
- Province / Facility
- Can Tho · 92003
|
893100130725 |
1%, tube 20g
Topical
|
Tube |
0
|
22,400
|
0
|
N4 |
Medipharco Pharmaceutical JSC
Vietnam
|
Can Tho
92003
|
2026-03-23 |
|
Sulfadiazin bạc
Sulfadiazin bac
- Strength / route
- 1%, tube 20g · Topical
- Qty
- 2,500 Tube
- Total
- 56,000,000
- Group
- N4
- Manufacturer
- Medipharco Pharmaceutical JSC (Vietnam)
- Province / Facility
- Can Tho · 92003
|
VD-28280-17 |
1%, tube 20g
Topical
|
Tube |
2,500
|
22,400
|
56,000,000
|
N4 |
Medipharco Pharmaceutical JSC
Vietnam
|
Can Tho
92003
|
2026-03-23 |
|
Survanta
Surfactant (Phospholipid chiet xuat tu phoi lon or phoi bo)
- Strength / route
- 25mg/ml - 4ml · Endotracheopulmonary
- Qty
- 10 Vial
- Total
- 88,022,000
- Group
- N1
- Manufacturer
- AbbVie Inc. (United States)
- Province / Facility
- Thua Thien Hue · 46204
|
QLSP-940-16 |
25mg/ml - 4ml
Endotracheopulmonary
|
Vial |
10
|
8,802,200
|
88,022,000
|
N1 |
AbbVie Inc.
United States
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Survanta
Surfactant (Phospholipid chiet xuat tu phoi lon or phoi bo; or chat dien hoat chiet xuat tu phoi bo (Bovine lung surfactant))
- Strength / route
- 25mg/ml - 4ml · Endotracheopulmonary
- Qty
- 90 Vial
- Total
- 792,198,000
- Group
- N1
- Manufacturer
- AbbVie Inc. (United States)
- Province / Facility
- Thua Thien Hue · 46001
|
QLSP-940-16 |
25mg/ml - 4ml
Endotracheopulmonary
|
Vial |
90
|
8,802,200
|
792,198,000
|
N1 |
AbbVie Inc.
United States
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Symbicort Rapihaler
each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg
- Strength / route
- each dose xit contains: Budesonid 160mcg + Formoterol fumarate dihydrate 4.5mcg; 120 dose · Inhalation
- Qty
- 4,000 Canister
- Total
- 1,736,000,000
- Group
- N1
- Manufacturer
- AstraZeneca Dunkerque Production (France)
- Province / Facility
- Quang Nam · 49004
|
300110006424 |
each dose xit contains: Budesonid 160mcg + Formoterol fumarate dihydrate 4.5mcg; 120 dose
Inhalation
|
Canister |
4,000
|
434,000
|
1,736,000,000
|
N1 |
AstraZeneca Dunkerque Production
France
|
Quang Nam
49004
|
2026-03-23 |
|
Symbicort Rapihaler
each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg
- Strength / route
- each dose xit contains: Budesonid 160mcg + Formoterol fumarate dihydrate 4.5mcg; 120 dose · Inhalation
- Qty
- 0 Canister
- Total
- 0
- Group
- N1
- Manufacturer
- AstraZeneca Dunkerque Production (France)
- Province / Facility
- Quang Nam · 49901
|
300110006424 |
each dose xit contains: Budesonid 160mcg + Formoterol fumarate dihydrate 4.5mcg; 120 dose
Inhalation
|
Canister |
0
|
434,000
|
0
|
N1 |
AstraZeneca Dunkerque Production
France
|
Quang Nam
49901
|
2026-03-23 |
|
Symbicort Rapihaler
Budesonid + formoterol
- Strength / route
- (160mcg + 4.5mcg) - 120 dose · Inhalation
- Qty
- 2,000 Canister
- Total
- 868,000,000
- Group
- N1
- Manufacturer
- AstraZeneca Dunkerque Production (France)
- Province / Facility
- Thua Thien Hue · 46204
|
300110006424 |
(160mcg + 4.5mcg) - 120 dose
Inhalation
|
Canister |
2,000
|
434,000
|
868,000,000
|
N1 |
AstraZeneca Dunkerque Production
France
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Symbicort Rapihaler
Budesonid + formoterol
- Strength / route
- (160mcg + 4.5mcg) - 120 dose · Inhalation
- Qty
- 3,000 Canister
- Total
- 1,302,000,000
- Group
- N1
- Manufacturer
- AstraZeneca Dunkerque Production (France)
- Province / Facility
- Thua Thien Hue · 46001
|
300110006424 |
(160mcg + 4.5mcg) - 120 dose
Inhalation
|
Canister |
3,000
|
434,000
|
1,302,000,000
|
N1 |
AstraZeneca Dunkerque Production
France
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Symbicort Turbuhaler
Budesonid + formoterol
- Strength / route
- each dose phong thich contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg · Inhalation
- Qty
- 900 Ampoule
- Total
- 197,100,000
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ca Mau · 96019
|
VN-20379-17 |
each dose phong thich contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg
Inhalation
|
Ampoule |
900
|
219,000
|
197,100,000
|
N1 |
AstraZeneca AB
Sweden
|
Ca Mau
96019
|
2026-03-23 |
|
Symbicort Turbuhaler
Budesonide; Formoterol fumarate dihydrate
- Strength / route
- each dose phong thich contains: Budesonid 160mcg + Formoterol fumarate dihydrate 4.5mcg; 60 dose · Inhalation
- Qty
- 3,000 Ampoule
- Total
- 657,000,000
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Quang Nam · 49004
|
VN-20379-17 |
each dose phong thich contains: Budesonid 160mcg + Formoterol fumarate dihydrate 4.5mcg; 60 dose
Inhalation
|
Ampoule |
3,000
|
219,000
|
657,000,000
|
N1 |
AstraZeneca AB
Sweden
|
Quang Nam
49004
|
2026-03-23 |
|
Symbicort Turbuhaler
Budesonide; Formoterol fumarate dihydrate
- Strength / route
- each dose phong thich contains: Budesonid 160mcg + Formoterol fumarate dihydrate 4.5mcg; 60 dose · Inhalation
- Qty
- 0 Ampoule
- Total
- 0
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Quang Nam · 49901
|
VN-20379-17 |
each dose phong thich contains: Budesonid 160mcg + Formoterol fumarate dihydrate 4.5mcg; 60 dose
Inhalation
|
Ampoule |
0
|
219,000
|
0
|
N1 |
AstraZeneca AB
Sweden
|
Quang Nam
49901
|
2026-03-23 |
|
Symbicort Turbuhaler
Budesonid + formoterol
- Strength / route
- (160mcg + 4.5mcg) - 60 dose · Inhalation
- Qty
- 1,200 Ampoule
- Total
- 262,800,000
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Thua Thien Hue · 46204
|
VN-20379-17 |
(160mcg + 4.5mcg) - 60 dose
Inhalation
|
Ampoule |
1,200
|
219,000
|
262,800,000
|
N1 |
AstraZeneca AB
Sweden
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Symbicort Turbuhaler
Budesonid + formoterol
- Strength / route
- (160mcg + 4.5mcg) - 120 dose · Inhalation
- Qty
- 1,200 Ampoule
- Total
- 520,800,000
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Thua Thien Hue · 46204
|
VN-20379-17 |
(160mcg + 4.5mcg) - 120 dose
Inhalation
|
Ampoule |
1,200
|
434,000
|
520,800,000
|
N1 |
AstraZeneca AB
Sweden
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Symbicort Turbuhaler
Budesonid + formoterol
- Strength / route
- (160mcg + 4.5mcg) - 60 dose · Inhalation
- Qty
- 1,000 Ampoule
- Total
- 219,000,000
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-20379-17 |
(160mcg + 4.5mcg) - 60 dose
Inhalation
|
Ampoule |
1,000
|
219,000
|
219,000,000
|
N1 |
AstraZeneca AB
Sweden
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Symbicort Turbuhaler
Budesonid + formoterol
- Strength / route
- (160mcg + 4.5mcg) - 120 dose · Inhalation
- Qty
- 2,000 Ampoule
- Total
- 868,000,000
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-20379-17 |
(160mcg + 4.5mcg) - 120 dose
Inhalation
|
Ampoule |
2,000
|
434,000
|
868,000,000
|
N1 |
AstraZeneca AB
Sweden
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Sympal
Dexketoprofen (as Dexketoprofen trometamol) 25mg
- Strength / route
- 25mg · Oral
- Qty
- 1,000 Tablet
- Total
- 5,513,000
- Group
- N1
- Manufacturer
- Manufacturing site: A. Menarini Manufacturing Logistics and Services S.r.l (Testing site: A. Menarini Manufacturing Logistics and Services S.r.l) (Manufacturing site: Italy (Testing site: Italy))
- Province / Facility
- Thua Thien Hue · 46204
|
VN2-522-16 |
25mg
Oral
|
Tablet |
1,000
|
5,513
|
5,513,000
|
N1 |
Manufacturing site: A. Menarini Manufacturing Logistics and Services S.r.l (Testing site: A. Menarini Manufacturing Logistics and Services S.r.l)
Manufacturing site: Italy (Testing site: Italy)
|
Thua Thien Hue
46204
|
2026-03-23 |
|
Sympal
Dexketoprofen (as Dexketoprofen trometamol) 50mg/2ml
- Strength / route
- 50mg/2ml · Injection
- Qty
- 1,000 Ampoule
- Total
- 21,210,000
- Group
- N1
- Manufacturer
- A. Menarini Manufacturing Logistics and Services S.r.l (Italy)
- Province / Facility
- Thua Thien Hue · 46001
|
VN-22698-21 |
50mg/2ml
Injection
|
Ampoule |
1,000
|
21,210
|
21,210,000
|
N1 |
A. Menarini Manufacturing Logistics and Services S.r.l
Italy
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Sympal
Dexketoprofen (as Dexketoprofen trometamol) 25mg
- Strength / route
- 25mg · Oral
- Qty
- 6,000 Tablet
- Total
- 33,078,000
- Group
- N1
- Manufacturer
- Manufacturing site: A. Menarini Manufacturing Logistics and Services S.r.l (Testing site: A. Menarini Manufacturing Logistics and Services S.r.l) (Italy)
- Province / Facility
- Thua Thien Hue · 46001
|
VN2-522-16 |
25mg
Oral
|
Tablet |
6,000
|
5,513
|
33,078,000
|
N1 |
Manufacturing site: A. Menarini Manufacturing Logistics and Services S.r.l (Testing site: A. Menarini Manufacturing Logistics and Services S.r.l)
Italy
|
Thua Thien Hue
46001
|
2026-03-23 |
|
Sáng mắt
Thuc dia, Hoai son, Trach ta, Cuc hoa, Thao quyet minh, Ha kho thao, Ha thu o do, Duong quy
- Strength / route
- 125mg; 160mg; 40mg; 24mg; 50mg; 12,5mg; 40mg; 160mg · Oral
- Qty
- 150,000 Tablet
- Total
- 97,500,000
- Group
- N3
- Manufacturer
- Traphaco High-Tech JSC (Vietnam)
- Province / Facility
- Hanoi · 01043
|
VD-24070-16 |
125mg; 160mg; 40mg; 24mg; 50mg; 12,5mg; 40mg; 160mg
Oral
|
Tablet |
150,000
|
650
|
97,500,000
|
N3 |
Traphaco High-Tech JSC
Vietnam
|
Hanoi
01043
|
2026-03-23 |
